Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.38 |
| ▸ | PDE5A | O76074 | 3/20 | 0.37 |
| ▸ | PDE6C | P51160 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1913406 | 0.82 | PDE5A (0.55) | HPGDKMT2APDE5APDE6CHSD17B10 | |
| SCHEMBL3453681 | 0.82 | PDE5A (0.53) | PDE5APDE6CCA12CA9 | |
| SCHEMBL6638843 | 0.77 | PDE5A (0.54) | KMT2APDE5APDE6CHSD17B10LMNA | |
| SCHEMBL7449440 | 0.75 | PDE5A (0.56) | PDE5APDE6CCA12CA9 | |
| SCHEMBL5078828 | 0.75 | PDE5A (0.33) | HPGDKMT2APDE5APDE6C | |
| SCHEMBL7368938 | 0.73 | KMT2A (0.30) | HPGDKMT2APDE5A | |
| SCHEMBL5076135 | 0.70 | PDE5A (0.54) | PDE5A | |
| SCHEMBL145682 | 0.69 | PDE5A (0.77) | HPGDKMT2APDE5APDE6C | |
| SCHEMBL29707546 | 0.69 | PDE5A (0.77) | HPGDKMT2APDE5APDE6C | |
| SCHEMBL8344627 | 0.67 | PDE5A (0.70) | PDE5APDE6C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0702555-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | Pfizer Limited (GB) | 1996-03-27 | — | — | EP | claimed |
| WO-1994028902-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | PFIZER LIMITED (GB) | 1994-12-22 | — | — | WO | claimed |
| EP-1868590-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | Unimed Pharmaceuticals, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006113242-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | UNIMED PHARMACEUTICALS, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| EP-1404343-A4 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1404343-A2 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | Solvay Pharmaceuticals, Inc. (US) | 2004-04-07 | — | — | EP | disclosed |
| EP-1315502-A1 | METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN | Unimed Pharmaceuticals Inc. (US) | 2003-06-04 | — | — | EP | disclosed |
| WO-2003002123-A2 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002017927-A1 | METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN | UNIMED PHARMACEUTICALS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-0702555-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | Pfizer Limited (GB) | 1996-03-27 | — | — | EP | disclosed |
| WO-1994028902-A1 | PYRAZOLOPYRIMIDINONES FOR THE TREATMENT OF IMPOTENCE | PFIZER LIMITED (GB) | 1994-12-22 | — | — | WO | disclosed |